electroCore raises $50 mln from investor group
electroCore, which has developed non-invasive therapy for treatment of conditions in neurology, psychiatry, gastroenterology, among others, has raised $50 million from investors including Merck's Global Health Innovation Fund, Easton Capital and Core Ventures. electroCore's primary focus at present is cluster and migraine headaches.
1 July 2014•3 mins read
